Feedback / Questions
varlitinib (ASLAN001) - ASLAN
https://www.globenewswire.com/news-release/2019/09/19/1917777/0/en/ASLAN-Pharmaceuticals-Presents-Late-Breaking-Data-From-Phase-2-Study-in-China-Testing-Varlitinib-in-Second-Line-Biliary-Tract-Cancer-at-CSCO.html
Sep 19, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next